{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:37:19Z","timestamp":1773293839203,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/iae.0000000000000748","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T09:04:46Z","timestamp":1443171886000},"page":"611-618","source":"Crossref","is-referenced-by-count":71,"title":["CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS"],"prefix":"10.1097","volume":"36","author":[{"given":"Quraish","family":"Ghadiali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse J.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy.","volume":"9","author":"Hayashi","year":"1986","journal-title":"Int Ophthalmol"},{"key":"R2-22-20210130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":". Digital indocyanine-green videoangiography of central serous chorioretinopathy.","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R3-22-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy.","volume":"121","author":"Prunte","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R5-22-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.121.7.975","article-title":". Topical fundus pulsation measurements in patients with active central serous chorioretinopathy.","volume":"121","author":"Tittl","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R6-22-20210130","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.05-0268","article-title":". Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy.","volume":"46","author":"Tittl","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-22-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology.","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R8-22-20210130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"R9-22-20210130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IAE.0b013e318251a3a8","article-title":"Choroidal imaging using spectral-domain optical coherence tomography.","volume":"32","author":"Regatieri","year":"2012","journal-title":"Retina"},{"key":"R10-22-20210130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/IAE.0b013e31821801c5","article-title":". Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.","volume":"31","author":"Kim","year":"2011","journal-title":"Retina"},{"key":"R11-22-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00164568","article-title":"Six cases of central serous choroidopathy induced by systemic corticosteroid therapy.","volume":"60","author":"Harada","year":"1985","journal-title":"Doc Ophthalmol"},{"key":"R12-22-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy.","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"R13-22-20210130","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","article-title":". Central serous chorioretinopathy in endogenous hypercortisolism.","volume":"111","author":"Bouzas","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R14-22-20210130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy.","volume":"81","author":"Garg","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R15-22-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":". Systemic findings associated with central serous chorioretinopathy.","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R16-22-20210130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":". Corticosteroids and central serous chorioretinopathy.","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"R17-22-20210130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0161-6420(02)01975-9","article-title":"Endocrine abnormalities in patients with central serous chorioretinopathy.","volume":"110","author":"Haimovici","year":"2003","journal-title":"Ophthalmology"},{"key":"R18-22-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":". Risk factors for central serous chorioretinopathy: a case-control study.","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"R19-22-20210130","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bjo.2004.054247","article-title":"Intravitreal triamcinolone acetonide and central serous chorioretinopathy.","volume":"89","author":"Jonas","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R20-22-20210130","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":". Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R21-22-20210130","first-page":"1369","article-title":"Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report.","volume":"17","author":"Gruszka","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R22-22-20210130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":". Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"R23-22-20210130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","article-title":". Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.","volume":"23","author":"Yannuzzi","year":"2003","journal-title":"Retina"},{"key":"R24-22-20210130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":". Pachychoroid pigment epitheliopathy.","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R25-22-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone.","volume":"31","author":"Struthers","year":"2007","journal-title":"Clin Cardiol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:11:36Z","timestamp":1620940296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201603000-00022"}},"subtitle":["A ONE-YEAR PILOT STUDY"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000748","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725809719.793520170","asserted-by":"object"}]},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}